UK: National Level Healthcare Changes

Published on January 19, 2023

The 2019 NHS Long Term Plan and the Health and Care Bill are sparking changes across the UK healthcare system. Industry experts Cal Foden, Francesca Murphy, Graham Tatham, and Rachel Rowbottom reveal what these changes mean on a national level, and how manufacturers should adapt.

Special thanks to Sam Calderwood for contributing to this article.

Significant changes are underway for the UK healthcare system at both the national and sub-national level, driven in part by the publication of the NHS Long Term Plan in 2019 and the drafting of the Health and Care Bill.

In this brief, we are focusing on key national level changes to the UK healthcare system, such as the creation of the Innovative Medicines Fund (IMF) to support patient access through funding clinically promising treatments (despite existing data uncertainty), and the replacement of the end-of-life criterion with an incremental cost-effectiveness ratio (ICER) threshold weighting…

Continue reading on website
Other news

2022 China MedTech Industry Outlook

January 19, 2023
We recently released our annual China Medtech Outlook for this year, and highlighted three key trends for the industry. Industry players will need to better assess the trends and implications, proactively adapt to changes, and continue to innovate on multiple dimensions to survive and thrive. Building on ongoing dialogues and in-depth discussions with leaders of the MedTech industry, our China Med

Innovate: 4 key questions to consider when (re-)imagining your portfolio for sustainability

January 19, 2023
As resources and input materials become increasingly expensive – through scarcity or regulation – companies can accelerate their sustainability efforts and turn such situations into opportunities. Innovation is key and we have summarized the four fundamental questions to pose when (re-)imaging existing product and service portfolios for sustainability. This post describes the second phase – innova